Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minakata

Showing results (671-680 of 752) with videos related to

Pageof 76
Sort By:
International Journal of Hematology|January 3, 2024
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional studyDaisuke Minakata, Tomoyuki Uchida, Aya Nakano, et al.
Journal of Gastroenterology and Hepatology|December 5, 2025
Objective Assessment of Visibility of Colorectal Lesions Using Eye Tracking for New Image-Enhanced Endoscopy ObservationAiji Hattori, Hiroaki Ikematsu, Hiroki Yamashita, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host DiseaseYasufumi Kawasaki, Kazuya Sato, Hiroko Hayakawa, et al.
Leukemia & Lymphoma|June 9, 2016
Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphomaKento Umino, Shin-Ichiro Fujiwara, Shoko Ito, et al.
Journal of Neurophysiology|March 4, 2003
PRQFVamide, a novel pentapeptide identified from the CNS and gut of AplysiaY Furukawa, K Nakamaru, K Sasaki, et al.
Plos One|January 11, 2021
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine modelsKiyomi Mashima, Iekuni Oh, Ken Fujiwara, et al.
Transplantation and Cellular Therapy|August 13, 2023
Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective AnalysisKazuhito Suzuki, Yutaka Shimazu, Daisuke Minakata, et al.
Leukemia Research|January 22, 2016
A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysisDaisuke Minakata, Shin-ichiro Fujiwara, Shoko Ito, et al.
Hematology (Amsterdam, Netherlands)|March 1, 2018
Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangementKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Hematology (Amsterdam, Netherlands)|April 18, 2017
Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOPKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pageof 76

Showing results (671-680 of 752) with videos related to

Sort By:
Pageof 76
International Journal of Hematology|January 3, 2024
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional studyDaisuke Minakata, Tomoyuki Uchida, Aya Nakano, et al.
Journal of Gastroenterology and Hepatology|December 5, 2025
Objective Assessment of Visibility of Colorectal Lesions Using Eye Tracking for New Image-Enhanced Endoscopy ObservationAiji Hattori, Hiroaki Ikematsu, Hiroki Yamashita, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host DiseaseYasufumi Kawasaki, Kazuya Sato, Hiroko Hayakawa, et al.
Leukemia & Lymphoma|June 9, 2016
Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphomaKento Umino, Shin-Ichiro Fujiwara, Shoko Ito, et al.
Journal of Neurophysiology|March 4, 2003
PRQFVamide, a novel pentapeptide identified from the CNS and gut of AplysiaY Furukawa, K Nakamaru, K Sasaki, et al.
Plos One|January 11, 2021
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine modelsKiyomi Mashima, Iekuni Oh, Ken Fujiwara, et al.
Transplantation and Cellular Therapy|August 13, 2023
Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective AnalysisKazuhito Suzuki, Yutaka Shimazu, Daisuke Minakata, et al.
Leukemia Research|January 22, 2016
A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysisDaisuke Minakata, Shin-ichiro Fujiwara, Shoko Ito, et al.
Hematology (Amsterdam, Netherlands)|March 1, 2018
Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangementKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Hematology (Amsterdam, Netherlands)|April 18, 2017
Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOPKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pageof 76